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Abstract
Genotyping of Mycobacterium tuberculosis has been extensively used for investigating epidemics of multidrug-resistant strains of M. tuber-
culosis, in order to identify the factors involved in the transmission of such strains and determine effective control programmes to limit
their expansion at both the individual and population levels. Here, we review the methods currently used to study the molecular epide-
miology of multidrug-resistant M. tuberculosis strains, and the insights provided by these techniques regarding global trends and the
transmission dynamics of multidrug-resistant tuberculosis at a world scale.
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Introduction
Multidrug resistance, i.e. resistance to at least rifampin and
isoniazid, in Mycobacterium tuberculosis is caused by the
sequential accumulation of mutations in the genes encoding
the targets of rifampin and isoniazid. Extensively drug-resis-
tant (XDR) tuberculosis (TB) is deﬁned as multidrug resis-
tance (resistance to isoniazid and rifampin), plus resistance
to a ﬂuoroquinolone and any of the injectable second-line
drugs (amikacin, capreomycin, or kanamycin). The emergence
and spread of multidrug-resistant (MDR) and XDR TB is
hampering efforts to control and manage TB. Since the
emergence of MDR strains in the 1990s, the prevalence of
MDR TB has slowly but constantly increased, such that it
now accounts for approximately 5% of global TB cases.
According to the Multidrug and extensively drug-resistant TB
2010 Global report on surveillance and response, it can be
estimated that 440 000 cases of MDR TB emerged globally
in 2008, causing an estimated 150 000 deaths [1]. More wor-
risome is the emergence of XDR TB, a nearly untreatable
form of the disease with an estimated rate of 15% among
the MDR strains [2]. In this review, the insights provided by
molecular epidemiology with regard to global trends of
transmission of MDR M. tuberculosis strains are presented
and discussed in light of the actual expansion of MDR/XDR
TB.
Current Methods used for the Molecular
Typing of MDR/XDR Strains of
M. tuberculosis
Restriction fragment length polymorphism (RFLP) analysis of
IS6110 insertion sequence relies on the determination of the
number of copies and location of insertion on the chromo-
some of the IS6110 element [3]. This technique is generally
recognized as a reference standard for strain differentiation
in molecular epidemiological studies, and has been widely
used for the identiﬁcation and investigation of outbreaks, the
identiﬁcation of laboratory cross-contamination, and distinc-
tion between re-infection and relapse [3]. However, the
method has several disadvantages that seriously limit its use
in routine practice: it has poor discriminatory power when
applied to isolates with a low IS6110 copy number, it is
labour-intensive, it requires signiﬁcant amounts of high-qual-
ª2011 The Author
Clinical Microbiology and Infection ª2011 European Society of Clinical Microbiology and Infectious Diseases
REVIEW 10.1111/j.1469-0691.2011.03577.x
ity DNA, and it generates band patterns that are difﬁcult to
share between laboratories.
Spoligotyping, which is based on polymorphisms in the
clustered regularly interspaced short palindromic repeats
(CRISPRs), can be used for both epidemiology and evolution-
ary analysis of M. tuberculosis [4]. Technically, the method is
based on the ampliﬁcation and detection of the presence or
absence of non-repetitive sequences called spacers found
between direct repeat elements in the CRISPR region [5].
Because it is based on PCR ampliﬁcation, spoligotyping can
be performed with very small quantities of DNA, so the
method does not require the handling of large amounts of
resistant isolates. Over the years, the signatures given by the
43 spacer-spoligotyping patterns have been used to deﬁne
strain families and create a very useful nomenclature with
which to describe the circulating genotypes of tubercle bacilli
worldwide (Table 1) [6]. As compared with the other molec-
ular methods, the main limitation of spoligotyping is its infe-
rior discriminatory power, especially in some lineages such
as the Beijing strains, which nearly all share a single spoligo-
type.
Variable numbers of tandem repeats (VNTR) analysis is a
powerful method that can provide adequate discrimination of
M. tuberculosis strains, in terms of both identiﬁcation of
genetic lineages and estimation of M. tuberculosis transmission
[7]. The method, which is PCR-based, relies on the analysis
of tandem repeats present in 41 genetic elements (called
mycobacterial interspersed repetitive units (MIRUs)) scat-
tered throughout the M. tuberculosis genome, with a variable
number of copies of the repeat unit in each locus. MIRU-
VNTR analysis, which is a PCR-based approach, is relatively
safe when applied to MDR strains, and generates numerical
values that can easily be compared in interlaboratory studies.
This method has other major advantages, such as its use for
phylogenetic analysis supported by a dedicated website
(MIRU-VNTRplus, available at http://www.miru-vntrplus.org/),
and a discriminatory power that is generally regarded as
being similar to that of IS6110-RFLP. Owing to its acceptable
discriminatory power and the exchangeable format of the
data generated by the method, MIRU-VNTR typing is consid-
ered to be the new reference standard for molecular epide-
miological studies.
Phylogeographical Analysis of MDR/XDR
M. tuberculosis Strains
An overall picture of the epidemiology of MDR TB in the
world can be drawn from the multiple studies that have anal-
ysed, by applying genetic approaches such as IS6110-RFLP,
spoligotyping, and MIRU-VNTR, the speciﬁc situations
encountered in representative areas of the world. Such stud-
ies are summarized hereafter, with the goal of presenting the
landscape of MDR/XDR TB diversity in the world.
In China, the rate of MDR TB (8% in 2007) is signiﬁcantly
higher than the global average rate, and represents a major
public health challenge [8]. In this country, and more gener-
ally on the Asian continent, the Beijing family is very com-
mon, with a prevalence that exceeds 50% in many countries
(China, South Korea, Hong Kong, and Thailand) [9]. A very
recent study based on the use of spoligotyping and MIRU-
VNTR determined the transmission characteristics of
M. tuberculosis isolates in a province of China where the Beij-
ing family prevails [8]. Strikingly, 90% of the strains were
found to have the Beijing family genotype, and, among these,
27% were MDR. The clustering rate among the MDR strains
was rather low (10%), indicating that these strains are char-
acterized by a signiﬁcant level of genomic diversity.
In Japan, the frequencies of MDR TB and XDR TB are
approximately 1.9% and 0.5%, respectively [10]. The trans-
mission dynamics of MDR TB and XDR TB were analysed
by IS6110-RFLP, spoligotyping and MIRU-VNTR on a set of
38 MDR and 17 XDR isolates [10]. The genetic family that
dominated was found to be Beijing (62%), followed by T
(13%), Latin American–Mediterranean (LAM) (5%), U (2%),
East African–Indian (EAI) (2%) and X (2%). Interestingly, the
proportion of Beijing genotype did not differ signiﬁcantly
between the MDR non-XDR and the XDR strains, but 70%
of the XDR strains were involved in clusters, indicating that
the XDR TB cases in Japan are more likely to be associated
with clustering than the non-XDR TB cases (38% of clus-
tered strains among the non-XDR cases) [10]. One possible
explanation that could account for the high clustering rate
of XDR TB reported in this study is that new cases of XDR
TB are more likely to be caused by transmission than by
acquisition of multidrug resistance resulting from treatment
failure.
TABLE 1. Major phylogenetic lineages within the Mycobac-
terium tuberculosis complex (MTBC) strains adapted to
humans
MTBC species
LSP-based lineage
nomenclature
Spoligotype-based
families
M. tuberculosis Indo-Oceanic EAI
M. tuberculosis East Asian Beijing
M. tuberculosis East African–Indian CAS
M. tuberculosis Euro-American H, LAM, X,
T, S, others
M. africanum West African I AFRI2
M. africanum West African II AFRI1
AFRI, M. africanum; CAS, Central Asian; EAI, East African–Indian; H, Haarlem;
LAM, Latin American–Mediterranean; LSP, large sequence polymorphism.
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A very similar study was conducted in Taiwan by investi-
gating, with spoligotyping and MIRU-VNTR, the transmission
and predominant genotypes involved in MDR TB [11]. In this
region, where the prevalence of MDR TB was 4% in 2004–
2008, the Beijing family genotype was still found to be the
predominant genotype among the MDR strains (48%),
followed by the Haarlem (15%) and T1 (4%) genotypes.
Approximately 62% of the strains were clustered into ten
clusters, and the largest cluster belonged to the Beijing geno-
type, a point that conﬁrms the signiﬁcant role played by this
lineage in the extensive transmission of MDR TB in Taiwan.
India has one of the highest estimated rates of TB in
the world, and accounts for 21% of all TB cases [12]. In
this country, it is estimated that 1–3.4% of new patients
are infected by an MDR M. tuberculosis strain [13]. An anal-
ysis of MDR isolates by spoligotyping indicated that the
most prevalent strain family is represented by the Beijing
lineage (41%), followed by the EAI (27%), Manu1 (20%)
and Central Asian (CAS) (17%) lineages [14]. Thus, despite
the fact that the proportion of Beijing strains remains
quite low in India (predominant spoligotypes belong to the
Central Asian Delhi family), it seems that there is an asso-
ciation between the Beijing lineage and MDR TB in this
country [14,15].
The epidemiological situation that prevails in eastern Eur-
ope and in the Russian Federation and the former Soviet
Union countries is exempliﬁed by the paper published by
Niemann et al. [16], who analysed the population structure
of M. tuberculosis complex strains from the Republic of Geor-
gia by 24-locus MIRU-VNTR and spoligotyping. In this coun-
try, the frequency of MDR strains can reach levels of up to
40% among previously treated patients. Strikingly, MDR TB
seems to be mostly associated with the diffusion of the Beij-
ing lineage (77% of the MDR isolates), thus conﬁrming that
Beijing strains represent a major factor driving the MDR TB
epidemic in eastern Europe [16]. Regarding the Russian Fed-
eration, a recent study has applied molecular typing to a
panel of 76 MDR M. tuberculosis strains circulating in Mos-
cow; it showed that 48% of the strains were grouped into
12 clusters, ten of them including strains belonging to the
Beijing family, which represented 78% of the MDR strains
[17]. Interestingly, the level of clustered strains was espe-
cially high (40%) for Beijing strains in the group of patients
who had not been treated previously, an observation that
was interpreted as evidence for the active transmission of
such strains [17].
It is interesting to note that, in spite of the geographical
proximity of countries where the Beijing sublineages are
highly prevalent, the phylogenetic distribution observed in
Sweden is very different from that reported for Russia and
the Baltic countries. According to Ghebremichael et al. [18],
only 13% of the patients with MDR TB were found to have
Beijing strains, and the majority of these patients came from
Asia (75%). Thus, in spite of the geographical proximity of
Russia and the Baltic states, there is no extensive spreading
of Beijing strains from these regions within any of the Scandi-
navian countries (in Finland and Denmark, the incidence of
Beijing strains remains very low) [18].
A study published in 2010 presented a spoligotype-based
analysis of MDR M. tuberculosis isolates in circulation in
Poland, which is representative of the population structure
characteristic of a European country [19]. Globally, the MDR
strains were characterized by high genotypic diversity and a
high number of unique proﬁles. Nevertheless, four major lin-
eages, i.e. the T, Haarlem, LAM and Beijing families, consti-
tuted more than 67% of the strains studied, showing the
compactness at the phylogenetic level of the MDR M. tuber-
culosis population structure in Poland. The highest number of
MDR strains belonged to the ill-deﬁned T family (28%), fol-
lowed by the Haarlem (17%) and LAM (13%) families, the
Beijing genotype accounting only for 9% of the MDR strains
[19]. The three major genotype families found in this study
(Haarlem, LAM, and T) are dominant in many European
countries, where they represent up to 60% of M. tuberculosis
strains found in Italy, 70% of those found in Sweden, and
80% of those found in Portugal [19]. In Poland, the low pro-
portion of Beijing MDR strains (9%) contrasts with the high
proportion of TB cases attributable to this lineage in the
countries of the former Soviet Union (approximately 30–
50%). Nonetheless, the presence of the Beijing lineage exclu-
sively in the MDR group suggests that the ongoing transmis-
sion of Beijing strains is a signiﬁcant cause of MDR TB in
Poland. Interestingly, most of these strains were isolated
from non-migrant patients born in Poland, which suggests
that active transmission of MDR Beijing strains within the
autochthonous population occurs in parallel with the more
commonly observed transmission from immigrants from Asia
and eastern Europe.
When compared to that in Poland, the population struc-
ture of the MDR isolates circulating in Portugal presents
interesting characteristics. This country has the fourth high-
est TB incidence rate in the European Union, with high levels
of MDR TB (primary rate, 1.5%; retreatment cases, 2.4%)
[20]. A study based on MIRU-VNTR typing indicates that a
large proportion (55%) of the MDR strains from the Lisbon
area belong to a single family related to the LAM genotype
(referred to as the Lisboa family in the Perdigao’s report),
which caused a large MDR TB outbreak in the Lisbon region
at the beginning of the 1990s. More alarming is the fact that
53% of these strains were XDR TB isolates, which repre-
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sents the highest XDR TB rate ever reported [21]. Thus, the
development of XDR TB observed in the Lisbon region
probably results from the circulation in the community of
Lisboa MDR strains for more than 10 years, which has per-
mitted the progressive acquisition of resistance to second-
line drugs [21].
Finally, the population structure of the MDR isolates cir-
culating in France has been evaluated by applying spoligotyp-
ing and 24-locus MIRU-VNTR to a panel of 98 MDR strains
collected by the French National Reference Centre (CNR
MyRMA) during the period 2009–2010 (Sougakoff W, Veziris
N, Millot G, Bastian S, Jarlier V, unpublished data). The over-
all distribution of the lineages on a map according to the
patients’ country of birth conﬁrms the predominance of the
Beijing family among the MDR strains obtained from patients
born in central Europe, eastern Europe, and Asia (approxi-
mately 75% of the MDR strains in this group of patients)
(Fig. 1). Regarding the group of patients born in Africa, one
can note a greater diversity of lineages, with a majority of
strains being assigned to the ill-deﬁned T lineage (52%), and
the remainder to the T1-Ghana, Haarlem, LAM, Cameroon,
TUR and Beijing families (Fig. 1). The MDR strains obtained
from the patients born in France (10% of the MDR TB cases)
were also found to belong to different lineages (Beijing,
Ghana, T, LAM, and S) (Fig. 1). The minimum spanning tree
shown in Fig. 2 reveals the high genetic heterogeneity and the
complexity of the population structure for the MDR strains,
with 13 clusters of strains sharing identical MIRU codes and
representing 41% of the tested isolates. Six of the 13 clusters
were attached to the Beijing genotype family within a single
clonal complex encompassing 19% of the MDR strains (clonal
complex 1 in Fig. 2). It is noticeable that no apparent epide-
miological link was found for a majority (67%) of the MDR
strains found in the six Beijing clusters, emphasizing the diver-
sity of the Beijing strains circulating in France.
Conclusions and Projections for the Future
Molecular ﬁngerprinting methods have undoubtedly had a
very signiﬁcant impact on ascertainment of the phylogeny of
the bacilli that account for the worldwide diffusion of MDR
TB and XDR TB, and elucidatation of the route of transmis-
sion of MDR TB. The report published in 2010 by Brown
et al. [22] clearly conﬁrms the tendencies highlighted by the
various reports presented in this review. First, there is a
strong association between a patient’s country of origin and
the family of the MDR isolates: Beijing dominates in patients
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FIG. 1. Geographical distribution of the lineages of multidrug-resistant strains (n = 98) received in 2009–2010 by the French National Reference
Centre for mycobacteria (CNR MyRMA), according to the country of birth of the patients. The diameters of coloured circles are proportional
to the numbers of strains belonging to a given lineage. The colour indicates the mycobacterial interspersed repetitive unit (MIRU)-24-deﬁned
lineage to which each strain is related: Beijing is red, T is dark blue, T1-Ghana is light green, Haarlem is green, LAM is dark green, Cameroon is
yellow–orange, TUR is blue, S is light blue, Dehli/CAS is green–khaki, and undetermined types are pink and violet.
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born in East Asia, whereas CAS, EAI and Beijing dominate in
patients born on the Indian subcontinent [22]. In contrast,
the strains grouped in the Euro-American superfamily
(encompassing the LAM, Haarlem and T lineages) are infre-
quent in these regions, but are globally equally distributed in
all other regions of the world. The other important and
worrying conclusion that can be drawn from genotyping
studies is that the Beijing family could be strongly associated
with multidrug resistance [22], and has spread globally in
recent years, now representing a major factor driving the
MDR TB epidemic in the world [16]. In this context, molecu-
lar epidemiology of MDR M. tuberculosis should progress to
improve our capacity to detect chains of transmission and
enhance TB control activities.
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